Covid Vaccines and ‘Emergency Use’ Authorization Explained.
David Dodd discussing COVID-19 Vaccines and 'Emergency Use' Authorization
https://youtu.be/Ppx8gQyYj8s?si=ACG31q97BSIBif4z&t=30
EMERGENCY USE AUTHORIZATION EXPLAINED
https://www.youtube.com/embed/iGkwaESsGBQ
FDA is globally respected for its scientific standards of vaccine safety, effectiveness and...
Revive’s Quarterly Report, Discussion, and a Video!
With 5,000 hospitalizations reported daily (150,000 a month), contracting Covid is not something to be taken lightly - after you get it.
Unless of...
Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and agree on...
Bavarian Nordic (BVNRY) Bags $119 Million Order from Joe Biden.
We Were up 80% on Bavarian For a Little While There. The Stock Looks Better Today, Then When we Originally Added to Watch List....
Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?
Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found in Virtually all...
Institutional Analyst Newsletter. April 14, 2022.
Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict
LIVE QUOTE
What Do We Have in April's Bag of Tricks?1. Revive Therapeutics (RVVTF) Moves a...
Report on Citius Pharma (CTXR): North Shore Research Issues a $10 Price Target, a...
We're Up 181% on Citius Pharma (CTXR), Despite its Being Well Below it's Recent High of $4.30. We Now Have Two $10 Price Targets....
Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...
Two Binary Events Directly Ahead.
As in Months Away, not Years. Share Price up 76% During April.
As we stated earlier, Revive Therapeutics (RVVTF)...
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, April 11, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...
Latest article
Report: Fairchild Gold Corp (FAIR). Proven Ground Mining.
When World-Class Management Shows Up at a $15 Million Company, You Pay Attention.
Three Projects Acquired in Nevada's Premier Mining Jurisdiction .. Now Awaiting Exploration.
Junior...
Annette L. Redmond Joins Strategic Advisory Board at Sekur Private Data (SWISF).
Former U.S. State Department Deputy Assistant Secretary
Decorated intelligence and cybersecurity executive with four decades of U.S. government leadership joins Sekur to advise on secure...
10X Alerts: Sekur Private Data (SWISF) Pushes SekurOne Closer to Market With First International...
Sekur has completed its first domestic and international encrypted calls on SekurOne and launched the platform’s voice, email, messenger, and VPN capabilities on Android...
